AKESF 财务： Akeso Inc AI 分析

Q: 技术分析指标如何适用于 AKESF？

根据技术分析，Akeso Inc 的综合信号为 Buy。Akeso Inc 有 4 个买入信号，2 个中性信号和 1 个卖出信号。

Q: AKESF 的斐波那契回调水平是多少？

Akeso Inc 的斐波那契回调水平是 低于100%的水平。

Q: Akeso Inc 的 RSI 是多少？

Akeso Inc 的 RSI 目前为 49.93，表明处于 中立 状态

Q: Akeso Inc 接下来 12 个月的价格是多少？

Akeso Inc AKESF 接下来 12 个月的价格预计为 $22.41。

Q: Akeso Inc 预计会涨到多高？

据华尔街分析师称，Akeso Inc 预计将达到 $30.73 的高预测值。

主页

股票

AKESF

预测

AKESF 股票价格预测

Akeso Inc

$15.47

-0.19%

$-0.02

收盘价：Jan 16, 16:00:00 GMT-5

$15.55

0.51%

$0.08

盘后：Jan 16, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$15.5

开盘价

$15.53

当日区间

$15.47 - $16.1

52周范围

$6.81 - $23.15

交易量

平均成交量

1.1K

每股收益（TTM）

-0.14

股息收益率

市值

$14.3B

什么是 AKESF？

Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for AKESF in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $22.41. The lowest target is $13.08 and the highest is $30.73. Empower your investment choices with our cutting-edge, data-driven analysis!

AKESF 股价预测摘要

AKESF的顶级分析师评级

基于 29 位分析师对 AKESF 的股票评级，更新于 Sep 01, 2025

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for AKESF. Our analysts highlight strong fundamentals and favorable market sentiment, positioning AKESF for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: AKESF is a Strong Buy candidate.

AKESF stock price ended at $15.5 on 星期四, after dropping 5.66%

On the latest trading day Jan 15, 2026, the stock price of AKESF fell by 5.66%, dropping from $15.50 to $15.50. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $15.50 and a high of $15.50. On the latest trading day, the trading volume for AKESF rose by 40 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 155 shares were traded, with a market value of approximately $14.2B.

AKESF 技术面信号

技术面信号摘要

购买信号 4

中性信号 2

卖出信号 1

Strong Sell

Sell

Neutral

Buy

Strong Buy

AKESF目前显示4个买入信号和1个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-5.66%。总体而言，技术指标显示中期前景为Buy。

AKESF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 AKESF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 AKESF？



AKESF 的斐波那契回调水平是多少？



Akeso Inc 的 RSI 是多少？



Akeso Inc 接下来 12 个月的价格是多少？



Akeso Inc 预计会涨到多高？



Akeso Inc（AKESF）价格

AKESF 股价走势图